Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) FCF Margin (2018 - 2025)

Precision Biosciences (DTIL) has disclosed FCF Margin for 8 consecutive years, with 32.95% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 291063.0% to 32.95% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 192.41% through Dec 2025, down 10697.0% year-over-year, with the annual reading at 192.41% for FY2025, 10697.0% down from the prior year.
  • FCF Margin for Q4 2025 was 32.95% at Precision Biosciences, up from 117461.54% in the prior quarter.
  • The five-year high for FCF Margin was 409.49% in Q1 2021, with the low at 117461.54% in Q3 2025.
  • Average FCF Margin over 5 years is 15122.39%, with a median of 195.51% recorded in 2022.
  • Peak annual rise in FCF Margin hit 291063bps in 2025, while the deepest fall reached -11642838bps in 2025.
  • Over 5 years, FCF Margin stood at 397.32% in 2021, then soared by 47bps to 212.07% in 2022, then skyrocketed by 44bps to 119.31% in 2023, then tumbled by -2367bps to 2943.57% in 2024, then soared by 99bps to 32.95% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 32.95%, 117461.54%, and 112627.78% for Q4 2025, Q3 2025, and Q2 2025 respectively.